A filler complication assessment begins before any product is dissolved, injected or prescribed. The first task is to establish whether the presentation is evolving, whether tissue is threatened, and whether the apparent problem is truly related to filler. Calm, structured clinical reasoning protects the patient from two equal risks: delayed treatment of a serious event and unnecessary intervention in a benign or unrelated condition.
Dermal filler complications range from transient oedema and bruising to vascular compromise, infection, inflammatory reactions, nodules and delayed facial change. Their appearances can overlap. A pale, painful area shortly after treatment demands a very different response from a soft, non-tender irregularity identified months later. Assessment must therefore be chronological, anatomical and clinically disciplined.
Why filler complication assessment requires a framework
The increasing sophistication of aesthetic medicine has brought greater expectations of safety, documentation and informed decision-making. Patients may arrive at a clinic distressed, having received treatment elsewhere, with incomplete records and advice gathered from social media. The clinician's role is not simply to identify a product-related problem. It is to assess risk, preserve tissue, communicate honestly and organise appropriate escalation.
A reliable framework prevents visual impressions from becoming premature diagnoses. Swelling may represent normal post-procedure inflammation, hypersensitivity, infection, lymphatic disturbance or trauma. Redness may be inflammatory, infective or vascular. Pain can be expected after a procedure, but disproportionate, escalating or persistent pain should always sharpen concern.
The assessment should also recognise that fillers are not a single category. Product composition, cross-linking, volume, injection plane, injection technique and anatomical site all influence likely complications and treatment options. Hyaluronic acid fillers may be amenable to enzymatic dissolution; other materials demand a different diagnostic and management pathway. A clinician should never assume product identity without evidence.
Establish the timeline before treating the symptom
The timing of onset is among the most valuable diagnostic clues. Immediate events, occurring during treatment or within hours, raise concern for vascular compromise, acute hypersensitivity, bruising, haematoma or early contour irregularity. Presentations over subsequent days may indicate infection, persistent oedema, inflammatory response or evolving tissue injury. Late presentations, weeks to years afterwards, may include delayed inflammatory nodules, biofilm-associated infection, product migration, granulomatous reaction or changes associated with illness, dental treatment or immune activation.
A focused history should establish the date and location of every aesthetic procedure, not only the most recent filler treatment. Ask what product was used, how much was injected, whether a cannula or needle was used, and whether there was immediate pain, blanching, visual disturbance or an unusual reaction. Previous dissolving procedures, facial surgery, dental work, recent infection, vaccination, autoimmune disease, medication changes and prior episodes are also relevant.
Where records are available, obtain them. Product labels, batch numbers, treatment charts and photographs may materially alter management. Where records are unavailable, document uncertainty rather than allowing the patient’s recollection to become a clinical fact.
Examine the patient, not just the area of concern
A thorough examination starts with the patient’s general condition. Fever, malaise, tachycardia, spreading erythema or regional lymphadenopathy change the level of concern. Facial assessment should then compare both sides in good light, at rest and during animation. Observe colour, capillary refill, temperature, oedema, asymmetry, livedo, skin integrity, ulceration and any distribution that follows a known vascular territory.
Palpation provides information that photography cannot. Determine whether a lesion is firm or fluctuant, tender or painless, mobile or fixed, superficial or deep. Assess warmth and whether pressure changes colour or discomfort. In suspected nodules, distinguish a discrete focal lesion from diffuse induration or oedema. In the lips and perioral region, examine intra-orally where appropriate, as dental and mucosal pathology can complicate the picture.
High-quality clinical photographs are part of patient safety, not an administrative afterthought. They provide a baseline, support serial assessment and assist discussion with other clinicians. Consent, confidentiality and secure storage remain essential.
Red flags that require urgent action
The following features warrant immediate senior assessment and, where indicated, urgent referral or emergency care:
- severe, disproportionate or increasing pain during or after injection;
- blanching, livedo reticularis, dusky discolouration, delayed capillary refill or cool skin;
- visual symptoms, including blurred vision, field loss, diplopia, ptosis or severe headache;
- rapidly spreading erythema, systemic illness, fever or signs of significant infection;
- skin breakdown, ulceration, necrosis or neurological symptoms.
Use imaging and investigation selectively
Clinical examination remains central, but imaging can be highly valuable when the diagnosis is uncertain or intervention carries risk. High-frequency ultrasound, in experienced hands, can help identify the location and depth of filler, distinguish product from fluid collection, guide aspiration where appropriate, and support more precise management. It is particularly useful in delayed swelling, persistent nodules, suspected migration and cases with an unclear treatment history.
Investigations should answer a clear question. If infection is suspected, sampling and microbiological assessment may be required before antimicrobial treatment, provided this does not delay urgent care. In complex or recurrent cases, collaboration with dermatology, plastic surgery, maxillofacial surgery, ophthalmology, radiology or infectious diseases may be necessary. Referral is not a failure of aesthetic practice. It is evidence of sound clinical judgement.
Differential diagnosis matters
Not every post-filler presentation is caused by filler. Acneiform disease, rosacea, herpes simplex, dental infection, contact dermatitis, sinus disease, salivary pathology and cutaneous malignancy can all appear in areas previously treated. Equally, a filler-related reaction can coexist with an unrelated condition.
The temptation to dissolve first and ask questions later is understandable, especially when a patient is anxious. Yet indiscriminate use of hyaluronidase may create further swelling, alter tissue appearance and obscure the underlying diagnosis. It may also be ineffective where the injected material is not hyaluronic acid or where the principal problem is infection, inflammatory disease or a non-filler pathology. Treatment should follow a working diagnosis, with the urgency of action proportionate to risk.
Documentation, communication and continuity of care
A complication assessment should record the patient’s account, relevant medical history, product information where known, examination findings, photographs, differential diagnosis, advice given and the rationale for any intervention or referral. Time-stamped documentation is particularly important in suspected vascular events, where the evolution of signs can guide decisions and demonstrate appropriate urgency.
Communication must be clear without being alarming. Patients should understand what is known, what remains uncertain, which symptoms demand immediate contact, and when they will be reviewed. Avoid reassurance that is stronger than the evidence permits. Equally, avoid language that implies blame before the facts are established, particularly when another practitioner provided the original treatment.
For clinics, the assessment also exposes the value of preparation. Emergency medicines and equipment, written escalation pathways, current anatomy training, consent processes and a culture in which staff can seek senior help early are foundational standards. In the educational approach championed by Professor Patrick Treacy, complications management is not separate from aesthetic excellence. It is one of its defining disciplines.
Clinical judgement is the essential safeguard
There is no single algorithm that can replace anatomical knowledge, experience and close observation. A small change in colour may be trivial in one patient and the first indication of significant vascular compromise in another. A late nodule may settle with conservative care, require imaging and targeted treatment, or reveal an alternative diagnosis entirely.
The most dependable approach is to assess early, document carefully, maintain a broad differential diagnosis and escalate without hesitation when tissue, vision or systemic health may be at risk. Patients remember not only the outcome, but whether their concern was taken seriously. That standard of attentive, medically led care is where safer aesthetic medicine begins.